Cheng Jiang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Machine Learning

Pulmonary Embolism

Artificial Intelligence

Top Venues

Expert opinion on drug safety

Therapeutic advances in drug safety

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Cheng Jiang, Jiancheng Qian, Xin Jiang, Shuohan Zhang, Junxian Zheng, Hongwei Wang
Is pitolisant safe for clinical use? A retrospective pharmacovigilance study focus on the post-marketing safety. Pharmacology research & perspectives 12 (1) (2024)
Xiaochen Wan, Shuohan Zhang, Cheng Jiang, Hongrui Zhang
Safety profile of lasmiditan: a retrospective post-marketing pharmacovigilance study based on the real-world data of FAERS database. Expert opinion on drug safety (2024)
Cheng Jiang, Xiaoxiao Zheng, Ping Li, Jiancheng Qian, Qin Li
A retrospective pharmacovigilance study of post-marketing safety concerns with cefuroxime. Therapeutic advances in drug safety 15 (2024)
Xiaochen Wan, Shuohan Zhang, Cheng Jiang, Hongrui Zhang
Safety profile of lasmiditan: a retrospective post-marketing pharmacovigilance study based on the real-world data of FAERS database. Expert opinion on drug safety (2024)
Cheng Jiang, Xiaoxiao Zheng, Ping Li, Jiancheng Qian, Qin Li
A retrospective pharmacovigilance study of post-marketing safety concerns with cefuroxime. Therapeutic advances in drug safety 15 (2024)
Cheng Jiang, Jiancheng Qian, Xin Jiang, Shuohan Zhang, Junxian Zheng, Hongwei Wang
Is pitolisant safe for clinical use? A retrospective pharmacovigilance study focus on the post-marketing safety. Pharmacology research & perspectives 12 (1) (2024)